Canadian trial tests monkeypox drug in outpatients
NCT ID NCT05534165
First seen Mar 05, 2026 · Last updated May 04, 2026 · Updated 6 times
Summary
This study tests whether the drug tecovirimat helps non-hospitalized adults with monkeypox heal faster. About 120 participants will receive either the drug or a placebo. The goal is to see if the drug speeds up skin lesion recovery and if such a trial is practical in Canada.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MONKEYPOX are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
St. Michael's Hospital
Toronto, Ontario, M5B 1W8, Canada
-
St. Paul's Hospital, BC Centre for Excellence in HIV/AIDS
Vancouver, British Columbia, V6Z 1Y6, Canada
-
Toronto General Hospital
Toronto, Ontario, M5G 2N2, Canada
Conditions
Explore the condition pages connected to this study.